News & Media
Factsheets (PDF)Press Releases (PDF)
- January 2008: Cellzome appoints Dr. Jane Dancer as VP Business Development [+]
- December 2007: Cellzome Establishes Scientific Advisory Board [+]
- November 2007: Cellzome CEO appointed to the Board of the UK's BioIndustry
Association [+] - August 2007: Cellzome publishes a Powerful 'Finger-Printing' Technology which Identifies Novel Targets for Gleevec™ [+]
- March 2007: Cellzome Receives First Milestone Payment for Alzheimer's Program from Ortho-McNeil Pharmaceutical, Inc. [+]
- January 2007: Cellzome Announces Extension of Drug Discovery Collaboration in Alzheimer's Disease with Ortho-McNeil Pharmaceutical, Inc. [+]
- January 2007: Cellzome scientists publish novel approach to quantitative proteomics in
Nature Biotechnology [+]
» Archive
Key Scientific Publications
- Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nature Biotechnolgy 25, 1035-1044 (2007) [+]
- Computational prediction of proteotypic peptides for quantitative proteomics.
Nature Biotechnolgy 25, 125-131 (2006) [+] - Proteome survey reveals modularity of the yeast cell machinery.
Nature 440, 631-636, 30 March 2006 [+] - A physical and functional map of the human TNF-α/NF-κB signal transduction pathway.
Nature Cell Biology 6, 97-105, 2004 (946 KB) [+] - Functional Organization of the Yeast Proteome by Systematic Analysis of Protein Complexes.
Nature 415, 141-147, 2002 (403 KB) [+]
Press Contacts
| Dr. Gitte Neubauer Vice President Research Operations Cellzome AG Tel. +49 (0) 6221 137 57 0 E-mail: press@cellzome.com |
Melanie Toyne-Sewell Director, Head of Life Sciences The Hogarth Partnership Tel: +44 (0) 20 7357 9477 E-mail: mtoyne-sewell@hogarthpr.co.uk |